性功能障碍

I. Eardley
{"title":"性功能障碍","authors":"I. Eardley","doi":"10.1093/med/9780198746690.003.0254","DOIUrl":null,"url":null,"abstract":"Male sexual dysfunction is common, with the most common types being erectile dysfunction, premature ejaculation, penile deformity, and priapism. Erectile dysfunction is common, becomes commoner with increasing age, and is often associated with cardiovascular disease and its risk factors. Patient assessment should seek to identify causative risk factors and treatment in the first instance is usually the management of risk factors and oral pharmacotherapy with a phosphodiesterase type 5 inhibitor. In women, sexual desire disorders are commoner in older postmenopausal women and a new treatment, flibanserin, has recently been licensed for this indication. Sexual arousal disorders in women also become more common postmenopausally and have a multifactorial aetiology. Treatment should be directed at the aetiological factor in the first instance while trials of oral pharmacotherapy for this condition have been disappointing.","PeriodicalId":347739,"journal":{"name":"Oxford Textbook of Medicine","volume":"52 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sexual dysfunction\",\"authors\":\"I. Eardley\",\"doi\":\"10.1093/med/9780198746690.003.0254\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Male sexual dysfunction is common, with the most common types being erectile dysfunction, premature ejaculation, penile deformity, and priapism. Erectile dysfunction is common, becomes commoner with increasing age, and is often associated with cardiovascular disease and its risk factors. Patient assessment should seek to identify causative risk factors and treatment in the first instance is usually the management of risk factors and oral pharmacotherapy with a phosphodiesterase type 5 inhibitor. In women, sexual desire disorders are commoner in older postmenopausal women and a new treatment, flibanserin, has recently been licensed for this indication. Sexual arousal disorders in women also become more common postmenopausally and have a multifactorial aetiology. Treatment should be directed at the aetiological factor in the first instance while trials of oral pharmacotherapy for this condition have been disappointing.\",\"PeriodicalId\":347739,\"journal\":{\"name\":\"Oxford Textbook of Medicine\",\"volume\":\"52 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oxford Textbook of Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/med/9780198746690.003.0254\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oxford Textbook of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/med/9780198746690.003.0254","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

男性性功能障碍是常见的,最常见的类型是勃起功能障碍、早泄、阴茎畸形和阴茎勃起障碍。勃起功能障碍是常见的,随着年龄的增长而变得常见,并且通常与心血管疾病及其危险因素有关。患者评估应寻求确定致病的危险因素,治疗通常首先是危险因素的管理和口服药物治疗磷酸二酯酶5型抑制剂。在女性中,性欲障碍在年龄较大的绝经后妇女中更为常见,一种新的治疗方法氟班色林(flibanserin)最近获准用于这一适应症。女性的性唤起障碍在绝经后也变得更加常见,并且具有多因素的病因。治疗应首先针对病因,而口服药物治疗的试验结果令人失望。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Sexual dysfunction
Male sexual dysfunction is common, with the most common types being erectile dysfunction, premature ejaculation, penile deformity, and priapism. Erectile dysfunction is common, becomes commoner with increasing age, and is often associated with cardiovascular disease and its risk factors. Patient assessment should seek to identify causative risk factors and treatment in the first instance is usually the management of risk factors and oral pharmacotherapy with a phosphodiesterase type 5 inhibitor. In women, sexual desire disorders are commoner in older postmenopausal women and a new treatment, flibanserin, has recently been licensed for this indication. Sexual arousal disorders in women also become more common postmenopausally and have a multifactorial aetiology. Treatment should be directed at the aetiological factor in the first instance while trials of oral pharmacotherapy for this condition have been disappointing.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信